UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 39

Sortiert nach

Bromodomain inhibitors, JQ1 and I-BET 762, as potential therapies for pancreatic cancer

Cancer letters, 2017-05, Vol.394, p.76-87

2017

Volltextzugriff (PDF)

Dimethyl fumarate and the oleanane triterpenoids, CDDO-imidazolide and CDDO-methyl ester, both activate the Nrf2 pathway but have opposite effects in the A/J model of lung carcinogenesis

Carcinogenesis (New York), 2015-07, Vol.36 (7), p.769-781

2015

Volltextzugriff (PDF)

Central Nervous System Inflammatory Aggregates in the Theiler's Virus Model of Progressive Multiple Sclerosis

Frontiers in immunology, 2019-08, Vol.10, p.1821-1821

2019

Volltextzugriff (PDF)

Differential neuro-immune patterns in two clinically relevant murine models of multiple sclerosis

Journal of neuroinflammation, 2019-05, Vol.16 (1), p.109-109, Article 109

2019

Volltextzugriff (PDF)

Intestinal Bacteroides modulates inflammation, systemic cytokines, and microbial ecology via propionate in a mouse model of cystic fibrosis

mBio, 2024-02, Vol.15 (2), p.e0314423

2024

Volltextzugriff (PDF)

The PARP Inhibitors, Veliparib and Olaparib, Are Effective Chemopreventive Agents for Delaying Mammary Tumor Development in BRCA1-deficient Mice

Cancer prevention research (Philadelphia, Pa.), 2014-07, Vol.7 (7), p.698-707

2014

Volltextzugriff (PDF)

The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of heme oxygenase-1 and Nrf2/ARE signaling

Cancer research (Chicago, Ill.), 2005-06, Vol.65 (11), p.4789-4798

2005

Volltextzugriff (PDF)

The synthetic triterpenoids CDDO-methyl ester and CDDO-ethyl amide prevent lung cancer induced by vinyl carbamate in A/J mice

Cancer research (Chicago, Ill.), 2007-03, Vol.67 (6), p.2414-2419

2007

Volltextzugriff (PDF)

Synthetic triterpenoids prolong survival in a transgenic mouse model of pancreatic cancer

Cancer prevention research (Philadelphia, Pa.), 2010-11, Vol.3 (11), p.1427-1434

2010

Volltextzugriff (PDF)

Sustained Release Talazoparib Implants for Localized Treatment of BRCA1 -deficient Breast Cancer

Theranostics, 2017-01, Vol.7 (17), p.4340-4349

2017

Volltextzugriff (PDF)

The Rexinoids LG100268 and LG101506 Inhibit Inflammation and Suppress Lung Carcinogenesis in A/J Mice

Cancer prevention research (Philadelphia, Pa.), 2016-01, Vol.9 (1), p.105-114

2016

Volltextzugriff (PDF)

The Synthetic Triterpenoid CDDO-Imidazolide Suppresses STAT Phosphorylation and Induces Apoptosis in Myeloma and Lung Cancer Cells

Clinical cancer research, 2006-07, Vol.12 (14), p.4288-4293

2006

Volltextzugriff (PDF)

CDDO-methyl ester delays breast cancer development in BRCA1-mutated mice

Cancer prevention research (Philadelphia, Pa.), 2012-01, Vol.5 (1), p.89-97

2012

Volltextzugriff (PDF)

Prevention and Treatment of Experimental Estrogen Receptor–Negative Mammary Carcinogenesis by the Synthetic Triterpenoid CDDO-Methyl Ester and the Rexinoid LG100268

Clinical cancer research, 2008-07, Vol.14 (14), p.4556-4563

2008

Volltextzugriff (PDF)

Triterpenoids CDDO-methyl ester or CDDO-ethyl amide and rexinoids LG100268 or NRX194204 for prevention and treatment of lung cancer in mice

Cancer prevention research (Philadelphia, Pa.), 2009-12, Vol.2 (12), p.1050-1058

2009

Volltextzugriff (PDF)

Novel semisynthetic analogues of betulinic acid with diverse cytoprotective, antiproliferative, and proapoptotic activities

Molecular cancer therapeutics, 2007-07, Vol.6 (7), p.2113-2119

2007

Volltextzugriff (PDF)

The Combination of the Rexinoid, LG100268, and a Selective Estrogen Receptor Modulator, Either Arzoxifene or Acolbifene, Synergizes in the Prevention and Treatment of Mammary Tumors in an Estrogen Receptor–Negative Model of Breast Cancer

Clinical cancer research, 2006-10, Vol.12 (19), p.5902-5909

2006

Volltextzugriff (PDF)

A novel acetylenic tricyclic bis-(cyano enone) potently induces phase 2 cytoprotective pathways and blocks liver carcinogenesis induced by aflatoxin

Cancer research (Chicago, Ill.), 2008-08, Vol.68 (16), p.6727-6733

2008

Volltextzugriff (PDF)

A New Rexinoid, NRX194204, Prevents Carcinogenesis in Both the Lung and Mammary Gland

Clinical cancer research, 2007-10, Vol.13 (20), p.6237-6243

2007

Volltextzugriff (PDF)

Pegylated interferon beta in the treatment of the Theiler's murine encephalomyelitis virus mouse model of multiple sclerosis

Journal of neuroimmunology, 2017-12, Vol.313, p.34-40

2017

Volltextzugriff (PDF)

Treatment of Theiler’s virus-induced demyelinating disease with teriflunomide

Journal of neurovirology, 2017-12, Vol.23 (6), p.825-838

2017

Volltextzugriff (PDF)

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Journal of visualized experiments, 2016-11 (117)

2016

Volltextzugriff (PDF)

Clinical utility of a molecular signature in inflammatory demyelinating disease

Neurology : neuroimmunology & neuroinflammation, 2019-01, Vol.6 (1), p.e520-e520

2019

Volltextzugriff (PDF)

Community composition and the environment modulate the population dynamics of type VI secretion in human gut bacteria

Nature ecology & evolution, 2023-12, Vol.7 (12), p.2092

2023

Volltextzugriff (PDF)

Interaction of PEGylated interferon-beta with antibodies to recombinant interferon-beta

International immunopharmacology, 2018-09, Vol.62, p.1-6

2018

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(39)

Sprache

Englisch
(39)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

Science & Technology
(30)
Life Sciences & Biomedicine
(29)
Animals
(26)
Mice
(24)
Oncology
(18)
Humans
(16)
Female
(13)
Oleanolic Acid - Analogs & Derivatives
(12)
Oleanolic Acid - Pharmacology
(10)
Biological And Medical Sciences
(8)
Cell Line, Tumor
(8)
Disease Models, Animal
(8)
Medical Sciences
(8)
Pharmacology. Drug Treatments
(7)
Antineoplastic Agents
(6)
Immunology
(6)
Anticarcinogenic Agents - Pharmacology
(5)
Antineoplastic Agents - Pharmacology
(5)
Apoptosis - Drug Effects
(5)
Cell Proliferation - Drug Effects
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Bromodomain inhibitors, JQ1 and I-BET 762, as potential therapies for pancreatic cancer

Dimethyl fumarate and the oleanane triterpenoids, CDDO-imidazolide and CDDO-methyl ester, both activate the Nrf2 pathway but have opposite effects in the A/J model of lung carcinogenesis

Central Nervous System Inflammatory Aggregates in the Theiler's Virus Model of Progressive Multiple Sclerosis

Differential neuro-immune patterns in two clinically relevant murine models of multiple sclerosis

Intestinal Bacteroides modulates inflammation, systemic cytokines, and microbial ecology via propionate in a mouse model of cystic fibrosis

The PARP Inhibitors, Veliparib and Olaparib, Are Effective Chemopreventive Agents for Delaying Mammary Tumor Development in BRCA1-deficient Mice

The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of heme oxygenase-1 and Nrf2/ARE signaling

The synthetic triterpenoids CDDO-methyl ester and CDDO-ethyl amide prevent lung cancer induced by vinyl carbamate in A/J mice

Synthetic triterpenoids prolong survival in a transgenic mouse model of pancreatic cancer

Sustained Release Talazoparib Implants for Localized Treatment of BRCA1 -deficient Breast Cancer

The Rexinoids LG100268 and LG101506 Inhibit Inflammation and Suppress Lung Carcinogenesis in A/J Mice

The Synthetic Triterpenoid CDDO-Imidazolide Suppresses STAT Phosphorylation and Induces Apoptosis in Myeloma and Lung Cancer Cells

CDDO-methyl ester delays breast cancer development in BRCA1-mutated mice

Prevention and Treatment of Experimental Estrogen Receptor–Negative Mammary Carcinogenesis by the Synthetic Triterpenoid CDDO-Methyl Ester and the Rexinoid LG100268

Triterpenoids CDDO-methyl ester or CDDO-ethyl amide and rexinoids LG100268 or NRX194204 for prevention and treatment of lung cancer in mice

Novel semisynthetic analogues of betulinic acid with diverse cytoprotective, antiproliferative, and proapoptotic activities

The Combination of the Rexinoid, LG100268, and a Selective Estrogen Receptor Modulator, Either Arzoxifene or Acolbifene, Synergizes in the Prevention and Treatment of Mammary Tumors in an Estrogen Receptor–Negative Model of Breast Cancer

A novel acetylenic tricyclic bis-(cyano enone) potently induces phase 2 cytoprotective pathways and blocks liver carcinogenesis induced by aflatoxin

A New Rexinoid, NRX194204, Prevents Carcinogenesis in Both the Lung and Mammary Gland

Pegylated interferon beta in the treatment of the Theiler's murine encephalomyelitis virus mouse model of multiple sclerosis

Treatment of Theiler’s virus-induced demyelinating disease with teriflunomide

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Clinical utility of a molecular signature in inflammatory demyelinating disease

Community composition and the environment modulate the population dynamics of type VI secretion in human gut bacteria

Interaction of PEGylated interferon-beta with antibodies to recombinant interferon-beta

Suchergebnisse filtern